Literature DB >> 11530807

Myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of Vater.

T Takahashi1, Y Kazama, H Shimizu, M Yoshimoto, M Tsujisaki, S Aoki, K Imai.   

Abstract

Patients with myelodysplastic syndrome (MDS) show a relatively high incidence of developing cancers. However, it is extremely rare that synchronous double cancers develop in an MDS patient. We report a case of MDS that progressed rapidly into erythroleukemia (M6 by French-American-British classification) complicated by gastric cancer and carcinoma of the papilla of Vater. A 66-year-old man was admitted because of pancytopenia with peripheral blasts. A diagnosis of MDS (with refractory anemia with excess of blasts in transformation [RAEB-T]) was made by bone marrow examination. Chromosome analysis revealed 46,XY. An early gastric cancer was also diagnosed by endoscopic examination. The peripheral blasts gradually proliferated and the disease progressed to M6. A chromosome abnormality 46,XY,del(1)(q42) was detected at the leukemic transformation. A CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen was started as a remission-induction therapy. However, obstructive jaundice developed and a marked dilatation of bile ducts was observed by abdominal computed tomography (CT). A carcinoma of the papilla of Vater was detected by endoscopy. As remission was achieved and the pancytopenia improved, the patient subsequently underwent a surgical jejuno-choledochostomy to manage the jaundice. However, the leukemia relapsed thereafter and additional chromosome abnormalities including der(5)t(5;10)(p15:q11) were observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530807     DOI: 10.1007/BF02982551

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

1.  Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.

Authors:  K Saito; Y Nakamura; M Aoyagi; K Waga; K Yamamoto; A Aoyagi; F Inoue; Y Nakamura; Y Arai; J Tadokoro; T Handa; S Tsurumi; H Arai; Y Kawagoe; H Gunnji; Y Kitsukawa; W Takahashi; S Furusawa
Journal:  Int J Hematol       Date:  2000-04       Impact factor: 2.490

2.  Primary myelodysplastic syndrome and cancer.

Authors:  R E Clark; H E Payne; A Jacobs; R R West
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-11

3.  [A case of erythroleukemia with multiple early carcinomas of the stomach].

Authors:  H Fujii
Journal:  Rinsho Ketsueki       Date:  1974-12

4.  Multiple primary cancers associated with hematological malignancies.

Authors:  E Nagura; K Kawashima; K Yamada
Journal:  Jpn J Clin Oncol       Date:  1985-04       Impact factor: 3.019

5.  [Double cancer in elderly patients with hematologic malignancies].

Authors:  N Niitsu; M Umeda
Journal:  Nihon Ronen Igakkai Zasshi       Date:  1996-04

6.  Immune-mediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features.

Authors:  R Billström; H Johansson; B Johansson; F Mitelman
Journal:  Eur J Haematol       Date:  1995-07       Impact factor: 2.997

7.  Erythroleukemia and gastric cancer following thorotrast injection.

Authors:  Y Hirose; S Konda; K Sasaki; F Konishi; E Takazakura
Journal:  Jpn J Med       Date:  1991 Jan-Feb

8.  Carcinoma of the ampulla of Vater synchronously associated with early gastric cancer--a report of two cases.

Authors:  H Yamashita; H Higashijima; K Fukushima; E Nagai; I Makino; S Okamoto; S Kuroki; H Ichimiya; K Chijiiwa
Journal:  Eur J Surg Oncol       Date:  1995-08       Impact factor: 4.424

9.  Advanced gastric cancer associated with acute myelocytic leukemia--report of a case.

Authors:  H Konno; K Ida; S Sakaguchi; K Aoki; S Baba; M Ihara
Journal:  Jpn J Surg       Date:  1991-09

10.  Low-dose melphalan for treatment of high-risk myelodysplastic syndromes.

Authors:  E Omoto; S Deguchi; S Takaba; K Kojima; T Yano; Y Katayama; K Sunami; M Takeuchi; F Kimura; M Harada; I Kimura
Journal:  Leukemia       Date:  1996-04       Impact factor: 11.528

View more
  4 in total

1.  Cervical carcinoma following myelodysplastic syndrome: A case report.

Authors:  DU Meng; Yan-Lan Chai; Yin-Fang He; Honglian Hu; Rui Liu; Zi Liu
Journal:  Oncol Lett       Date:  2014-04-11       Impact factor: 2.967

2.  Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else.

Authors:  Paula de Melo Campos; Fabiola Traina; Irene Lorand-Metze; Sara Teresinha Olalla Saad
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-17

3.  Synchronous primary duodenal papillary adenocarcinoma and gallbladder carcinoma: A case report and review of literature.

Authors:  Jing Chen; Ming-Yuan Zhu; Yan-Hua Huang; Zhong-Cheng Zhou; Yi-Yu Shen; Quan Zhou; Ming-Jian Fei; Fan-Chuang Kong
Journal:  World J Clin Cases       Date:  2022-09-26       Impact factor: 1.534

4.  Gastric carcinoma subsequent to myelodysplastic syndrome with t (1; 19) chromosome translocation: A rare case report and its potential mechanisms.

Authors:  Wenqing Yu; Gaoyang Chen; Yunpeng Sun; Sujun Gao; Wei Li; Jiuwei Cui; Jingnan Sun
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.